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Evaluation of Autonomic Dysfunction in Patients with Hepatic 
Cirrhosis 
 
1. Introduction:  
Cirrhosis of the liver leads to a   number of complications, some of which may 
eventually prove fatal. For more than a century, chronic alcoholics have been known to 
have peripheral neuropathy. It has been observed that alcoholics with liver damage have 
higher frequency of neuropathy than those without it. There are reports of association of 
chronic liver disease with autonomic neuropathy However; conflicting reports have also 
appeared causing much confusion. Patients with cirrhosis and portal hypertension develop 
hyper dynamic circulation, with increased blood volume and cardiac output, and with a 
reduced peripheral vascular   resistance. This disorder has been related to portal 
hypertension–induced arterial vasodilatation in the peripheral and splanchnic beds, but 
other factors may contribute, such as abnormally high levels of circulating vasodilators 
and false neurotransmitters.1 
Alterations in the autonomic nervous system’s drive to the heart and circulation may also 
occur in cirrhosis, as suggested by studies based on cardiovascular tests such as 
cardiovascular responsiveness to postural changes, exercise, and mental stress. These 
tests, however, have been criticized for being insensitive to early changes in the 
autonomic function, especially in the sympathetic nervous system. Recent evidence 
indicates that the spontaneous, small beat-to-beat fluctuations that are usually observed in 
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the continuous recordings of heart rate and arterial pressure reflect the activity of the 
efferent arc of the autonomic nervous sys tem that is modulating cardiovascular function. 
In particular, sympathetic and vagal outflows to the heart and circulation generate two 
main oscillatory rhythms: (1) a short-term rhythm, present in heart period and arterial 
pressure variabilities and defined as the low-frequency (LF) component, which is 
considered a marker of the sympathetic activity; and (2) a long-term rhythm, only 
occurring in heart period variability, related to respiration, and known as the high 
frequency (HF) component, which is thought to be a marker of the vagal modulation. 
These oscillatory components of heart rate and arterial pressure signals can be extracted 
from the variability signals through spectral analysis techniques. 
2. Back ground : 
Neural regulation of the gastrointestinal tract 
               The enteric nervous system plays an integral role in the regulation of gut 
mucosal and motor function. It is organized into two major plexuses.   The myenteric 
plexus lies between the external longitudinal and internal circular muscle layers. The 
submucosal plexus lies between the circular muscle layer and the mucosa.2 Although the 
enteric nervous system receives input from the central and autonomic nervous systems, it 
can function independently. Nerves of the myenteric plexus project fibers primarily to the 
smooth muscle of the gut, with only a few axons extending to the submucosal plexus. 
Most of the fibers of the submucosal plexus project into the mucosa and the submucosal 
and myenteric plexuses.  
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Figure :1   Pathways of sympathetic and parasympathetic innervations 
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Figure 2.    Organization of the enteric nervous system 
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Various peptide and nonpeptide neurotransmitters are found in the enteric nervous 
system3. Recent studies using immunohistochemical staining have localized 
neurotransmitters to specific neurons in the gastrointestinal tract. γ -Aminobutyric acid is 
found primarily in the myenteric plexus and is involved in regulating smooth muscle 
contraction. Serotonin is found within the plexus and functions as an interneuron 
transmitter. Adrenergic neurons originate in ganglia of the autonomic nervous system and 
synapse with enteric neurons. Peptides such as neuropeptide Y (NPY) are often secreted 
from the same adrenergic neurons and generally exert inhibitory effects such as 
vasoconstriction.4 Other adrenergic neurons containing somatostatin project to the 
submucosal plexus, where they inhibit intestinal secretion. Coexistence of peptides and 
neurotransmitters in the same neurons is not unusual; in fact, the interplay among 
transmitters is critical for coordinated neural regulation.5 For example, the peptides VIP 
and peptide histidine isoleucine (PHI) are commonly found together, as are the  
tachykinins substance P and substance K, where they have complementary effects. 
Somatostatin is found in interneurons that project caudally. The inhibitory action of 
somatostatin is consistent with a role in causing muscle relaxation in advance of a 
peristaltic wave. The abundance of VIP in the myenteric plexus also suggests that its 
inhibitory actions are important for smooth muscle relaxation in gut motility. VIP 
neurons that project from the submucosal plexus to the mucosa most likely stimulate 
intestinal fluid secretion. Other neurons that innervate the mucosa contain 
acetylcholine.Mucosal cells of the intestine contain receptors for both VIP and 
acetylcholine, allowing these transmitters to exert synergistic effects, because VIP 
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increases intracellular cyclic adenosine monophosphate (cAMP) levels and acetylcholine 
increases intracellular calcium in the target cell.6 
Bipolar neurons that project to the mucosa and myenteric plexus act as sensory neurons 
and often contain substance P and acetylcholine as neurotransmitters. These neurons 
participate in pain pathways and modulate inflammation.The ability of hormones to act 
on nerves locally within the submucosa of the intestine and affect more distant sites on 
nerves such as the vagus expands the potential organs that may be regulated by gut 
hormones. Chemical and mechanical stimuli cause the release of hormones from 
endocrine cells of the intestinal mucosa. These interactions initiate a wide variety of 
secretomotor responses, many of which are mediated by enteric neurons. Secretomotor 
circuits consist of intrinsic primary afferent neurons with nerve endings in the mucosa 
and extension through the myenteric and submucosal plexuses. This circuitry allows 
nerves to stimulate mucosal cells to secrete fluid and electrolytes and at the same time 
stimulate muscle contraction. The same motor neurons also have axons that supply 
arterioles and can initiate vasodilator reflexes. Extrinsic primary afferent neurons can be 
either of the vagus, with somal bodies in the nodose ganglia and axons that reach the gut 
through the vagus nerve, or of the spinal nerves of the thoracic and lumbar regions, 
whose cell bodies lie in the dorsal root ganglia. Information conducted by extrinsic 
primary afferent neurons includes pain, heat, and sensations of fullness or emptiness. 
These neurons are also targets for hormones. For example, the satiety effect of CCK in 
the bloodstream is mediated through the vagus nerve. Specific CCK receptors have been 
identified on the vagus, and blockade of these receptors abolishes the satiation induced by 
peripheral CCK.7 
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Endocrine, paracrine, and neural transmitters existing within the lamina propria modulate 
effects on the gut immune system. Lymphocytes, macrophages, mast cells, neutrophils, 
and eosinophils are potential targets for endocrine and neural transmitters and participate 
in the inflammatory cascade. Moreover, inflammatory mediators can act directly on 
enteric nerves. Serotonin released from endocrine cells is involved in intestinal 
anaphylaxis and stimulates vagal afferent fibers that possess the 5-hydroxytryptamine 3 
5-HT3) receptor. 
Chemical messengers of the gastrointestinal tract 
The enteric nervous system, through intrinsic and extrinsic neural circuits, controls 
gastrointestinal function. This control is mediated by a variety of chemical messengers, 
including motor and sensory pathways of the sympathetic and parasympathetic nervous 
systems. The parasympathetic preganglionic input is provided by cholinergic neurons and 
elicits excitatory effects on gastrointestinal motility via nicotinic and muscarinic 
receptors, whereas the sympathetic input occurs by postganglionic adrenergic neurons. 
Acetylcholine 
Acetylcholine is synthesized in cholinergic neurons and is the principal regulator of 
gastrointestinal motility as well as pancreatic secretion. Acetylcholine is stored in nerve 
terminals and released by nerve depolarization. Released acetylcholine is then able to 
bind to postsynaptic muscarinic and/or nicotinic receptors. Nicotinic acetylcholine 
receptors belong to a family of ligand-gated ion channels and are homopentamers or 
heteropentamers comprised of α, β , γ , δ , and ε subunits The α subunit is believed to be 
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the mediator of postsynaptic membrane depolarization following acetylcholine receptor 
binding. Muscarinic receptors belong to the heptahelical GPCR family. There are five 
known muscarinic cholinergic receptors (M1 to M5). Muscarinic receptors can be further 
classified based on receptor signal transduction, with M1, M3, and M5 stimulating 
adenylate cyclase and M2 and M4 inhibiting this enzyme. 
Acetylcholine is degraded by the enzyme acetylcholinesterase, and the products may be 
recycled through high-affinity transporters on the nerve terminal 
Catecholamines 
The primary catecholamine neurotransmitters of the enteric nervous system include 
norepinephrine and dopamine. Norepinephrine is synthesized from tyrosine and released 
from postganglionic sympathetic nerve terminals that innervate enteric ganglia and blood 
vessels. Tyrosine is converted to dopa by tyrosine hydroxylase. Dopa is initially 
converted into dopamine by dopa decarboxylase and packaged into secretory granules. 
Norepinephrine is formed from dopamine by the action of dopamine β -hydroxylase 
within the secretory granule. After an appropriate stimulus, norepinephrine-containing 
secretory granules are released from nerve terminals and bind to adrenergic receptors. 
Adrenergic receptors are G protein coupled, have seven typical membrane-spanning 
domains, and are of two basic types: α and β . α-Adrenergic receptors are further 
classified into α1A, α1B, α2A, α2B, α2C, and α2D. Similarly, β receptors include β 1, β 2, 
and β 3. Adrenergic receptors are known to signal through a variety of G proteins, 
resulting in stimulation or inhibition of adenylate cyclase and other effector systems. 
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Norepinephrine signaling is terminated by intracellular monoamine oxidase or by rapid 
reuptake by an amine transporter. The actions of adrenergic receptor stimulation regulate 
smooth muscle contraction, intestinal blood flow, and gastrointestinal secretion.8 
Dopamine is an important mediator of gastrointestinal secretion, absorption, and motility 
and is the predominant catecholamine neurotransmitter of the central and peripheral 
nervous systems. In the central nervous system, dopamine regulates food intake, 
emotions, and endocrine responses, and peripherally, it controls hormone secretion, 
vascular tone, and gastrointestinal motility.9 Characterization of dopamine in the 
gastrointestinal tract has been challenging for several reasons. First, dopamine can 
produce inhibitory and excitatory effects on gastrointestinal motility. Generally, the 
excitatory response, which is mediated by presynaptic receptors, occurs at a lower agonist 
concentration than the inhibitory effect that is mediated by postsynaptic receptors. 
Second, localization of dopamine receptors has been hampered by identification of 
dopamine receptors in locations that appear to be species specific. Finally, studies of 
dopamine in gastrointestinal tract motility have often used pharmacologic amounts of this 
agonist. Therefore, interpretation of results has been confounded by the ability of 
dopamine to activate adrenergic receptors at high doses. 
Classically, dopamine was thought to act via two distinct receptor subtypes: type 1 and 
type 2. Molecular cloning has now demonstrated five dopamine receptor subtypes, each 
with a unique molecular structure and gene locus. Dopamine receptors are integral 
membrane GPCRs, and each receptor subtype has a specific pharmacologic profile when 
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exposed to agonists and antagonists. After release from the nerve terminal, dopamine is 
cleared from the synaptic cleft by a specific dopamine transporter. 
Serotonin 
Serotonin has long been known to play a role in gastrointestinal neurotransmission. The 
gastrointestinal tract contains more than 95% of the total body serotonin, and serotonin is 
important in a variety of processes, including nausea, emesis, epithelial secretion, and 
bowel motility. Serotonin is synthesized from tryptophan, an essential AA, and is 
converted to its active form in nerve terminals. Serotonin is inactivated in the synaptic 
cleft by reuptake via a serotonin-specific transporter. Most plasma serotonin is derived 
from the gut, where it is found in mucosal enterochromaffin cells and the enteric nervous 
system. Serotonin mediates its effects by binding to a specific receptor. There are seven 
different serotonin receptor subtypes found on enteric neurons, enterochromaffin cells, 
and gastrointestinal smooth muscle (5-HT1 to 5-HT7). Through these receptors serotonin 
regulates intestinal secretion, absorption, and motility.  
Serotonin, and its receptor, has been implicated in the pathogenesis of irritable bowel 
syndrome, as well as constipation and diarrhea. The myenteric plexus contains serotonic 
interneurons that project to the submucosal plexus as well as ganglia extrinsic to the 
bowel wall. Extrinsic neurons activated by serotonin participate in bowel sensation and 
may be responsible for abdominal pain, nausea, and symptoms associated with irritable 
bowel syndrome. Intrinsic neurons activated by serotonin are primary components of the 
peristaltic and secretory reflexes responsible for normal gastrointestinal function.  
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Characterization of specific serotonin receptor subtypes has led to the development of 
selective agonists and antagonists for the treatment of gastrointestinal disorders such as 
irritable bowel syndrome and chronic constipation and diarrhea. For example, 5-HT3 
receptor antagonists may be useful in diarrhea-predominant irritable bowel syndrome, 
and the 5-HT4 receptor agonist has prokinetic effects and may be useful in constipation or 
other motility disorders.  
Histamine 
In the gastrointestinal tract, histamine is best known for its central role in regulating 
gastric acid secretion and intestinal motility. Histamine is produced by enterochromaffin-
like cells of the stomach and intestine as well as enteric nerves. Histamine is synthesized 
from l-histidine by histidine decarboxylase and activates three GPCR subtypes. H1 
receptors are found on smooth muscle and vascular endothelial cells and result in 
activation of phospholipase C (PLC). As such, the H1 receptor mediates many of the 
allergic responses induced by histamine. H2 receptors are present on gastric parietal cells, 
smooth muscle, and cardiac myocytes. H2 receptor binding stimulates Gs and activates 
adenylate cyclase. H3 receptors are present in the central nervous system and 
gastrointestinal tract endochromaffin cells. These receptors signal through Gi and inhibit 
adenylate cyclase. Histamine can also interact with theN-methyl-d-aspartate (NMDA) 
receptor and enhance activity of NMDA-bearing neurons independent of the three known 
histamine receptor subtypes. 
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Unlike other neurotransmitters, there is no known trans porter responsible for termination 
of histamine's action. However, histamine is metabolized to telemethylhistamine by 
histamine N-methyltransferase, and is then degraded to telemethylimidazoleacetic acid by 
monoamine oxidase B and an aldehyde dehydrogenase. 
Nitric Oxide 
Although smooth muscle physiologists have long known of an "endothelial-derived 
relaxing factor" responsible for vasodilation, it took many years for the chemical nature 
of this substance to be identified as nitric oxide (NO). NO is a unique chemical 
messenger produced with citrulline from l-arginine and oxygen by the enzyme nitric 
oxide synthase (NOS). Three types of NOS are known. Types I and III are also know as 
endothelial NOS and neuronal NOS and are constitutively active. Small changes in NOS 
activity can occur through elevations in intracellular calcium. The inducible form of NOS 
(type II) is apparent only when cells become activated by specific cytokines and 
inflammation. This form of NOS is capable of producing large amounts of NO and is 
calcium independent. NOS is often colocalized with VIP and PACAP in neurons of the 
enteric nervous system. 10 
NO, being an unstable gas, has a relatively short half-life. Unlike most neurotransmitters 
and hormones, NO does not act via a membrane-bound receptor. Instead, NO readily 
diffuses into adjacent cells to directly activate guanylate cyclase. NO activity is 
terminated by oxidation to nitrate and nitrite. The role of NO in gastrointestinal 
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physiology includes stimulation of epithelial secretion, vasodilation, and mucosal 
defense.  
Adenosine 
Adenosine is an endogenous nucleoside that acts through any of four GPCR subtypes. 
Adenosine causes relaxation of intestinal smooth muscle and stimulates intestinal 
secretion. Adenosine can also cause peripheral vasodilation and activation of nociceptors 
that participate in pain neural pathways. 
Cytokines 
Cytokines are a group of polypeptides produced by a variety of immunomodulatory cells 
and are involved in cell proliferation, immunity, and inflammation. Cytokines are 
induced by specific stimuli, such as toxins produced by pathogens, and often elicit a 
complex variety of other cellular mediators to eradicate the foreign substance. Cytokines 
may be categorized as interleukins (ILs), tumor necrosis factors (TNFs), lymphotoxins, 
interferons, colony-stimulating factors (CSFs), and others. Interleukins can be further 
subtyped into 17 separate substances: IL-1 to IL-17. There are two TNFs: TNF-α and 
TNF-β , which are also known as lymphotoxin-α. Interferons are produced during viral or 
bacterial infection and come in two varieties: interferon-α (also known as leukocyte-
derived interferon or interferon-β ) and interferon-γ . Interferon-α is produced by T 
lymphocytes and is used clinically in the treatment of viral hepatitis. The major CSFs are 
granulocyte/mononuclear phagocyte-CSF, mononuclear phagocyte-CSF, and 
granulocyte-CSF. These agents are used in chemotherapy-induced neutropenia and 
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marrow support after bone marrow transplantation. Chemokines initiate and propagate 
inflammation and are of two groups: CXC (α chemokines) and CC (β chemokines). Other 
cytokines, such as transforming growth factor (TGF)-β and platelet-derived growth factor 
(PDGF), have proliferative effects. 
Normal Liver Blood Flow 
          Hepatic blood flow is normally about 1500 mL/minute, representing 15% to 20% 
of cardiac output. One third of this flow and 30% to 60% of the oxygen consumed by the 
liver are provided by the hepatic artery. Approximately two thirds of the hepatic blood 
supply is provided by portal venous blood.7,11 The high-pressure, well-oxygenated arterial 
blood mixes completely with the low-pressure, low-oxygen-containing, nutrient-rich 
portal venous blood within the hepatic sinusoids. After perfusing the sinusoids, blood 
flows, sequentially, into the hepatic venules, hepatic veins, and inferior vena cava. A 
fraction of the plasma entering the space of Disse is drained into lymphatic vessels. 
A unique feature of the normal hepatic sinusoidal microcirculation is its low perfusion 
pressure. This low pressure is attributed to the unusually high precapillary to 
postcapillary resistance in the liver.11 It appears that the sinusoids are normally protected 
from upstream portal perfusion pressure and fluctuations in that pressure by a 
presinusoidal site of high resistance, probably within the terminal portal venous radicals. 
Because the sinusoids are lined by an endothelium that lacks a continuous basement 
membrane and contains a multitude of large (50 to 200 nm), highly permeable fenestrae, 
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maintenance of a low pressure in the hepatic sinusoids is critical to the maintenance of 
normal rates of transudation of sinusoidal fluid into the space of Disse. 
Another feature that is unique to the hepatic circulation is the close interrelationship 
between blood flow in the portal vein and that in the hepatic artery. When portal blood 
flow increases, hepatic arterial flow decreases; when portal flow decreases, hepatic 
arterial flow increases. This phenomenon has been termed the hepatic arterial buffer 
response and is an adenosine-mediated vascular reflex that ensures the maintenance of a 
relatively constant state of sinusoidal perfusion in the face of changes in portal inflow 
that occur, for example, with meals.      
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Figure 3.  Hemodynamic principles in portal hypertension 
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Hyperdynamic circulation is a common and long-recognized feature of patients with 
advanced cirrhosis, consisting of elevated cardiac rate and output and reduced peripheral 
vascular resistance, so that arterial pressure is tendentially or frankly reduced. The 
clinical importance of this disorder was shown by subsequent studies, showing that the 
alterations of systemic hemodynamics, renal function, and vasoactive systems are 
prognostic indicators even more accurate than the tests exploring liver function. The 
setting of the hyperdynamic circulatory syndrome is the pathogenetic background of 
complications such as renal sodium and water retention and hepatorenal 
syndrome.Splanchnic blood pooling, opening of portal-systemic collaterals, and arterial 
vasodilatation, as well as a compensatory increase in blood volume, are the causative 
events of the hyperdynamic circulatory syndrome. The pathogenesis of arterial 
vasodilatation is still debated. It has been proposed that an overproduction of a variety of 
vasorelaxant agents, such as histamine, adenosine, gut-derived peptides and endothelial 
cell-derived vasodilators, and bile acid retention reduce the responsiveness of the 
vascular bed to endogenous vasoconstrictor stimuli. 
                             There is abundant evidence for increased sympathetic nervous system 
tone in patients with cirrhosis. Serum norepinephrine levels are increased. However, 
considerable data point to the attenuation of sympathetic neurotransmitter effects in 
portal hypertension, in part as a result of down-regulation of adrenergic receptor density 
and in part as a result of postreceptor antagonism by opposing vasodilator influences. 
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Earlier studies showed that cross-perfusion between portal hypertensive and normal 
animals produces arteriolar vasodilation in the latter, lending support to the hypothesis 
that a transferable humoral vasodilator is present in the blood in portal hypertension. 
Much attention has since focused on putative vasoactive mediators responsible for the 
arteriolar vasodilation in splanchnic organs that underlies the increase in portal venous 
inflow. Investigators have postulated that endogenous vasodilators normally present in 
portal blood and cleared by the liver may escape hepatic removal either as a result of 
portosystemic shunting via portosystemic collaterals or as a result of impaired 
hepatocellular metabolism. A further possibility is that liver disease and portal 
hypertension lead to an increase in the production of certain vasodilators within either the 
hepatic or the splanchnic vascular beds. These vasodilators then reach high 
concentrations in the systemic circulation, thereby leading to systemic and splanchnic 
arterial vasodilation. 
Several gut peptide hormones have been proposed as vasodilator mediators in portal 
hypertension. Glucagon has been a prime candidate. Serum glucagon levels are increased 
in experimental models of portal hypertension and in patients with cirrhosis.Glucagon 
impairs systemic vascular sensitivity to norepinephrine A role for glucagon in portal 
hypertension is also supported by the finding of a significant reduction in splanchnic 
blood flow after infusion of a glucagon-specific antiserum However, this reduction in 
splanchnic blood flow was not accompanied by a reduction in systemic vasodilation. In 
addition, other investigators have found no correlation between the magnitude of arterial 
vasodilation and circulating levels of glucagon On the other hand, infusion of 
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pharmacologic doses of somatostatin or its synthetic analog octreotide, which decreases 
glucagon release, produces vasoconstriction of both the splanchnic and the systemic 
circulation. Because somatostatin also inhibits the release of several other peptide 
vasodilators, such as substance P, vasoactive intestinal peptide (VIP), and calcitonin 
gene-related peptide (CGRP), it is conceivable that the effects of somatostatin on the 
circulation in portal hypertension may be mediated by other peptides in addition to, or 
apart from, glucagon. Also, somatostatin may exert a direct vasoconstrictive effect on 
vascular smooth muscle. Therefore, understanding of the role of glucagon as a mediator 
of systemic vasodilation in portal hypertension remains inconclusive, but on the basis of 
available data, hyperglucagonemia may account for approximately 30% to 40% of the 
splanchnic vasodilation of chronic portal hypertension.  
Vasoactive factors produced by the vascular endothelium have attracted considerable 
attention with respect to a potential role in the pathogenesis of portal hypertension. There 
is increasing evidence for the involvement of nitric oxide (NO) and prostacyclin in the 
pathogenesis of the circulatory abnormalities in portal hypertension. 
NO is a powerful endogenous vasodilator that is generated in several tissues by a 
constitutive vascular endothelial NO synthase (eNOS) and an inducible NO synthase 
(iNOS) from the amino acid l-arginine. NO is produced constitutively by eNOS and by 
liver parenchymal and nonparenchymal cells after induction of iNOS by cytokines and 
endotoxin. An increasing body of evidence suggests that excessive NO biosynthesis by 
eNOS may be involved in the pathogenesis of the low systemic and splanchnic vascular 
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resistance and hence increased splanchnic arterial flow associated with portal 
hypertension.  
Tumor necrosis factor-α (TNF-α) mediates the effects of endotoxin, a potent stimulant of 
NOS. A dramatic amelioration in the hyperdynamic circulation and the increased portal 
pressure has been described in portal hypertensive rats treated with antibody to TNF-α.  
Administration of specific NO antagonists to animals with portal hypertension induces 
splanchnic and systemic vasoconstriction, thereby attenuating the hyperdynamic 
circulation. In addition, inhibition of NO synthesis, at least partially, corrects the blunted 
vascular responsiveness to vasoconstrictors that is characteristic of portal hypertension. 
The finding that patients with cirrhosis have increased serum and urinary concentrations 
of nitrite and nitrate (end-products of NO oxidation) also supports a role for NO in the 
genesis of the circulatory disturbances of portal hypertension. However, NO inhibition 
attenuates but does not normalize the hyperkinetic state of portal hypertension. Also, in 
one study chronic NO inhibition delayed but did not prevent the development of 
splanchnic vasodilation in experimental animals. These and other data suggest that other 
factors in addition to NO are involved in the vasodilatory phenomena associated with the 
hyperdynamic circulation of portal hypertension. 
Several studies have supported a role for prostaglandins in the hyperdynamic circulation 
of portal hypertension. Prostacyclin levels have also been found to be increased in the 
portal vein of portal hypertensive rats, whereas patients with cirrhosis have increased 
systemic and portal levels of prostacyclin. Portal levels of prostacyclin correlate with the 
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degree of portal pressure elevation in these patients. In one study inhibition of 
prostaglandin biosynthesis by indomethacin reduced the hyperdynamic circulation and 
portal pressure in patients who had cirrhosis and portal hypertension.  
A variety of other circulating vasodilators have been evaluated, including bile acids, 
histamine, adenosine, and substance P   without convincing evidence to date that they 
contribute to the systemic hyperdynamic state of portal hypertension. 
 
The autonomic nervous system plays a central role in modulating cardiac performance 
and vasomotor activity. The presence of an autonomic dysfunction (AD) in cirrhosis has 
been clearly shown through different experimental approaches, including the evaluation 
of the cardiovascular and sudomotor responses to physiological and pharmacological 
stimulation, and by showing a hyperproduction of weak adrenergic neurotransmitters. It 
has also been reported that the severity of AD is proportional to the severity of cirrhosis, 
and its presence is an indicator of poor prognosis in patients with both early and 
advanced liver disease.12 Finally, AD is associated with an impairment of free water 
generation and hyponatremia and is likely involved in the pathogenesis of prolonged 
electrocardiographic Q-T interval, a common finding in advanced cirrhosis with an 
adverse prognostic significance. Based on the previous discussion, we hypothesized that 
AD is involved in the pathophysiology of hyperdynamic circulation of advanced 
cirrhosis.  
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                                 The hyperdynamic circulation begins in the portal venous bed as a 
consequence of portal hypertension due to the increased resistance to flow from altered 
hepatic vascular morphology of chronic liver disease. Dilatation of the portal vein is 
associated with increased blood flow, as well as the opening up or formation of veno-
venous shunts and splenomegaly. At the same time, portal hypertension leads to 
subclinical sodium retention resulting in expansion of all body fluid compartments, 
including the systemic and central blood volumes. 
                       As liver disease progresses and liver function deteriorates, the systemic 
hyperdynamic circulation becomes more manifest with activation of the renin 
angiotensin--aldosterone system. The presence of vasodilatation in the presence of highly 
elevated levels of circulating vasoconstrictors may be explained by vascular 
hyporesponsiveness due to increased levels of vasodilators such as nitric oxide, as well as 
the development of an autonomic neuropathy. However, vasodilatation is not generalized, 
but confined to certain vascular beds, such as the splanchnic and pulmonary beds. Even 
here, the status may change with the natural history of the disease, since even portal 
blood flow may decrease and become reversed with advanced disease. The failure of 
these changes to reverse following liver transplantation may be due to remodeling and 
angiogenesis. Autonomic dysfunction (AD) is seen in both alcohol-induced and non-
alcohol- induced liver disease, and when present is an independent predictor of 
mortality.13 It is postulated that patients who were awaiting liver transplantation are likely 
to have a high prevalence of autonomic dysfunction with an associated increase in 
mortality Kaplan-Meier survival analysis showed a significantly higher mortality (P=.05) 
in patients with AN. On the basis of this observation, consideration should be given for 
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early liver transplantation in patients with advanced liver disease and autonomic 
dysfunction 
Alcohol related neuropathy 
The clinical symptoms of alcoholic peripheral neuropathy were described more than 200 
years ago. The descriptions by Lettsom (1787) and Jackson (1822) have led to the 
recognition and association of peripheral nerve disease with excessive ethanol use. 
Several terms connote alcohol neuropathy, including neuritic beriberi, neuropathic 
beriberi, and alcoholic neuritis. In patients with alcoholic neuropathy, nutritional 
deficiency goes hand in hand with alcohol abuse.  
The similarity between beriberi and alcoholic neuropathy had long been noted, but 
Shattuck in 1928 was the first to seriously discuss the relationship. He suggested that 
"polyneuritis of chronic alcoholism" was caused chiefly by failure to take or assimilate 
food containing a sufficient quantity of vitamin Bcomlex and might properly be regarded 
as true beriberi. However, this theory may be only partly true.  
Pathophysiology: The precise pathogenesis of alcohol neuropathy and autonomic 
dysfunction remains unclear. Separating ethanol use from nutritional and vitamin 
deficiencies, especially thiamine, has always been difficult and a source of long-standing 
debate. Nutritional deficiency (frequently associated with alcohol neuropathy) and/or the 
direct toxic effect of alcohol or both have been implicated and studied. In Wernicke-
Korsakoff syndrome, a clear association between reduction of thiamine levels or 
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thiamine-mediated enzyme activity (transketolase) has been established, though this has 
not been conclusively established in the case of peripheral neuropathy.  
In their comparison of alcoholics and nonalcoholic control subjects, Behse and 
Buchthal concluded that nutritional deficiencies alone did not produce the neuropathy. 
Monforte et al concluded that alcohol appears to be toxic to autonomic and peripheral 
nerves in a dose-dependent manner, on the basis of heart rate, blood pressure, and 
electrophysiologic examination. In a study of macaque monkeys, Hallet et al failed to 
produce clinical and electrophysiologic signs of neuropathy in monkeys that were given a 
certain amount of alcohol for 3-5 years.  
Studies in rats also failed to demonstrate a direct toxic effect of alcohol on the 
peripheral nerves. Most studies of peripheral neuropathy in humans and animals 
implicate nutritional deficiency as an etiology as opposed to the direct toxic effect of 
alcohol.13,14  
Frequency:  
Internationally: Depending on criteria and patient selection, incidence of peripheral  
neuropathy ranging from 10-50% has been reported. These studies included alcoholics  
hospitalized for other reasons or for detoxification.  
 
• Neuropathy is more prevalent in frequent, heavy, and continuous drinkers 
compared to more episodic drinkers . When electrodiagnostic criteria are added, 
neuropathy detection increases to 25-90%   
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Mortality/Morbidity: Johnson and Robinson studied the mortality rate of alcoholics 
with autonomic dysfunction.  
• Their findings suggested that evidence of vagal neuropathy in long-term 
alcoholics is associated with a significantly higher mortality rate than in the 
general population (a reported 88% survival rate at 7 years in alcoholics with 
autonomic dysfunction as compared to 94% in the general population).  
• Deaths due to cardiovascular disease are a major factor.  
• Many deaths were attributed to strokes, since heavy alcohol consumption is a 
significant risk factor for stroke.  
Sex:   
• A high incidence of alcoholic polyneuropathy has been observed in women.  
History: Clinical manifestations of alcoholic neuropathy can be summarized as slowly 
progressive (over months) abnormalities in sensory, motor, autonomic, and gait function. 
Patients might ignore early symptoms, and seek help only when significant complications 
develop. Symptoms are often indistinguishable from other forms of sensory motor axonal 
neuropathy.  
• Sensory symptoms include early numbness of the soles, followed by dysesthesias 
of feet and legs, especially at night. "Pins and needles" sensation, which is 
reported commonly, progresses to severe pain that is described as burning or 
 30
lancinating. Symptoms start typically distally, to progress slowly to involve 
proximally (dying-back neuropathy). When symptoms extend to involve above 
the ankle level, the fingertips often get similarly involved, giving rise to the well-
known stocking and glove pattern of sensory involvement. Paresthesia might 
become unpleasant, even painful.15 
• Motor manifestations include distal weakness and muscle wasting.  
• When proprioception becomes involved, sensory ataxia will occur giving rise to 
gait difficulty, independent of alcoholic cerebellar degeneration. 
• Autonomic disturbances are seen less commonly than other neuropathic 
conditions (eg, diabetes). 
o Dysphagia and dysphonia are prominent secondary to degeneration of the 
vagus nerve. Other parasympathetic abnormalities include depressed 
reflex heart rate responses, abnormal pupillary function, sexual impotence, 
and sleep apnea. 
o Sympathetic dysfunction is rare but if present can produce orthostatic 
hypotension and hypothermia. 
• Frequent falls and accidents are common. These are secondary to gait 
unsteadiness and ataxia that are caused by cerebellar degeneration, sensory ataxia, 
or distal weakness. 
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Physical: Examination shows distal sensory loss in lower extremities. In severe cases, the 
hands may be involved. In addition to distal atrophy and weakness, deep tendon reflexes 
usually are decreased or absent. Stasis dermatitis, glossiness, and thinness of skin of the 
lower legs are common findings. Hyperesthesia and hyperalgesia may be seen along with 
hyperpathia. Excessive sweating of the soles and dorsal aspects of the feet and of the 
palms and fingers is a common manifestation of alcoholic neuropathy and is indicative of 
involvement of the peripheral (postganglionic) sympathetic nerve fibers. Occurrence of 
trophic ulcers is rare.  
Causes:  
• Variants 
o Rare cases of acute or subacute alcoholic peripheral neuropathy have been 
described. They mimic Guillain-Barré syndrome, although biopsy and 
electrodiagnostic studies had revealed an axonal neuropathy, with normal 
CSF parameters. A causal but an unproven association with ethanol is 
present.16 
o Pressure palsies: Alcoholics with generalized axonal peripheral 
neuropathy are prone for pressure palsies at multiple sites. Associated 
nutritional deficiency and weight loss might potentiate the same. 
Neurapraxia is more common than axonotmesis, and recovery is often the 
rule, although elderly patients do poorly. 
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Lab Studies:  
• The diagnosis is based on accurate history of prolonged and excessive alcohol 
intake, clinical signs and symptoms, and electrophysiologic testing. Behse and 
Buchtal suggested that a minimum of 100 mL of ethyl alcohol (3 L of beer or 300 
mL of spirits) per day for 3 years will precipitate the neuropathy17. 
Other Tests:  
• Electrophysiologic findings primarily reveal evidence of primary axonal sensory 
motor polyneuropathy. 
o Sensory conduction studies may be abnormal even before the advent of 
clinical symptoms.  
 Sural nerve sensory action potentials (SNAP) are reduced slightly 
to moderately in conduction velocity and SNAP amplitudes also 
are reduced.  
 As the condition worsens, the sensory potentials may become 
unobtainable. The median, radial, and ulnar nerves show the same 
response as the disease progresses. 
o Motor conduction studies of the lower extremities (tibial and peroneal 
nerves) may reveal a slight reduction in conduction velocity (not to exceed 
70-80% of the lower limit of normal), with diminution of the compound 
muscle action potential (CMAP) amplitude with a slight prolongation in 
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distal latency. The upper extremity nerves follow the same pattern as time 
progresses.18 
o The tibial H reflex latency is prolonged and becomes unobtainable if the 
condition continues to progress. The F waves are obtained more easily but 
reveal slight to moderate prolongation of latency. 
• Needle electromyography (EMG) examination of the distal muscles of the lower 
extremities shows active denervation as well as chronic changes in the form of re-
innervation patterns.  
o Spontaneous activity (positive sharp waves and fibrillation) is seen in the 
tibialis anterior and gastrocnemius.  
o The motor unit action potentials are reduced in recruitment pattern, with 
high-amplitude, long-duration, and polyphasic motor units. 
• Avaria Mde et al (2004) have demonstrated that prenatal alcohol exposure is 
associated with abnormalities in nerve electrical properties and that the pattern is 
different from that seen in adults, showing conduction slowing and decrease in 
proximal and distal amplitude. Inference can be made by demonstrating other 
abnormalities of alcohol abuse, particularly abnormal liver function test results 
and red cell macrocytosis. Thiamine levels are not consistently reduced, but the 
thiamine-mediated enzyme transketolase estimation is often abnormal.19 
• Cerebrospinal fluid (CSF) is typically normal or might show a mildly elevated 
total protein level. 
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• Patients have an increased risk of compression neuropathy, and electrodiagnostic 
findings can be complicated by superimposed mononeuropathies that are present. 
Recent methods of demonstrating small-diameter fiber neuropathy, such as 
quantitative sensory testing and intraepidermal nerve fiber density, have been 
applied but need to be applied in large scale. 
• Sural nerve biopsy often shows evidence of generalized distal axonal loss 
affecting both large and small fibers but without distinctive pathologic features. 
• Autonomic testing of parasympathetic and sympathetic reflexes is often abnormal 
(25% in one study), including analysis of heart rate variability, Valsalva 
maneuver, handgrip, tilt table, and standing maneuvers . The pattern of 
abnormalities often resembles the changes in diabetes and other causes of 
autonomic failure.17 
Histologic Findings: Pathologic findings of the peripheral nerve in alcoholic neuropathy 
generally are agreed to consist of axonal degeneration with secondary segmental 
demyelination. 
Medical Care: Treatment is directed toward stopping further damage to the peripheral 
nerves and returning to normal functioning. These can be achieved by alcohol abstinence, 
a nutritionally balanced diet supplemented by all B vitamins, and rehabilitation. 
However, in the setting of ongoing ethanol use, vitamin supplementation alone has not 
been convincingly shown to be sufficient for improvement in most patients. 
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Prognosis:  
• The prognosis of alcoholic neuropathy generally is good, as reported by Hillbom 
and Wennberg in their series of 10 patients. 
o Provided that alcohol intake is discontinued and other causes of 
neuropathy (eg, malignancy, diabetes, nerve trauma) are carefully 
excluded, clinical and electrophysiologic examinations returned to normal 
or near normal. This is independent of age. 
o Prognosis is generally better in patients who are healthy and well 
nourished. Recovery is presumed to be due to regeneration and collateral 
sprouting of damaged axons. 
• Studies have shown that patients with mild-to-moderate neuropathy can 
significantly improve, but the improvement is usually incomplete in those with 
severe findings. 
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Hepatic disease–related neuropathy  
Hepatic disease–related neuropathies, as with primary biliary cirrhosis (PBC), can be 
associated with autonomic dysfunction in 48% of patients. The cause of autonomic 
dysfunction in hepatic disease remains unclear, but it may be associated with toxic 
metabolite accumulation or related immune-mediated mechanisms. It may be reversible 
following liver transplantation. Maheshwari et al (2004) hypothesized that patients with 
autonomic neuropathies are more likely to develop hepatic encephalopathy due to a 
decreased intestinal transit time.20 Although this group's study did not show an 
independent effect of autonomic dysfunction on hepatic encephalopathy, their findings 
did demonstrate that patients with autonomic neuropathies were more likely to develop 
new-onset hepatic encephalopathy. In general, patients present with symptoms of both 
sympathetic and parasympathetic dysfunction, with or without symptoms of somatic 
nervous system dysfunction 21 Some symptoms, such as those of orthostatic intolerance, 
are common in autonomic neuropathies, whereas other symptoms, such as complete 
anhidrosis, are rare as a primary manifestation. 
Orthostatic hypotension is often the first recognized symptom and typically is the 
most disabling 22. However, other autonomic symptoms can occur before syncope, and 
these include impotence or ejaculatory dysfunction, decreased sweating, and urinary 
incontinence. Careful attention to use and dosage of prescription medication as well as 
over-the-counter nutritional and other health or dietary supplements is important. 
Lightheadedness and low blood pressure upon rising, which can lead to unconsciousness 
in severe cases.  
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Ocular - Blurring then graying of vision, blacking out, tunnel vision, sensitivity to 
light, difficulty with focusing, reduced lacrimation, loss of pupillary size over time 
(which is often correlated with loss of visual symptoms) 
Cardiovascular - Orthostatic onset of palpitations, nausea, tremulousness, 
presyncope with light-headedness, visual blurring, tinnitus, and even chest pain and 
shortness of breath Orthostatic hypotension may follow and is often associated with 
postprandial state, alcohol, exercise, or temperature-induced exacerbation of hypotension. 
Supine hypertension and a loss of diurnal variation in blood pressure may occur later.23  
Micturition and defecation may induce presyncope. With worsening symptoms, 
episodes of syncope with complete loss of consciousness after standing may occur. In the 
most severe of autonomic neuropathies, orthostatic tolerance loss with inability to stand 
because of immediate syncope may occur. Episodes of palpitations, angina, dyspnea, and 
syncope may relate to cardiac arrhythmias as well. 
Gastrointestinal - Constipation, episodic diarrhea, early satiety, increased gastric 
motility, dysphagia, bowel atony, bowel incontinence, gastroparesis in diabetes mellitus 
(which may cause food stasis and subsequent vomiting, hyposalivation, and altered sense 
of taste24  
Renal - Nocturia, bladder urgency, bladder frequency, enuresis, incomplete 
bladder voiding, urinary retention, and urinary incontinence Sexual - Impotence (mainly 
parasympathetic) and loss of ejaculation (mainly sympathetic), retrograde ejaculation, 
and possibly, female sexual dysfunction Sweating - Anhidrosis or hypohidrosis, 
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compensatory hyperhidrosis, gustatorysweating (Watkins, 1987) (Hyperpyrexia may 
occur in severe anhidrosis.) 
Temperature regulation - Hypothermia (from loss of shivering and inability to 
vasoconstrict to prevent heat loss) and hyperpyrexia (may be of concern to patients with 
anhidrosis who are exposed to high temperatures) Feet - Burning feet most commonly 
observed in small-fiber sensory neuropathy (itching of feet may precede burning), 
pruritus, dysesthesia, allodynia, hyperalgesia, nocturnal exacerbation of symptoms, dry 
skin, loss of distal leg hair, brittle nails, pallor, and cold feet 
Techniques of physical examination  
Detailed neurologic examination should be performed to detect a somatic peripheral 
neuropathy. Motor examination should concentrate on the strength and muscle bulk of 
distal muscles, as well as on deep tendon reflexes. Sensory examination should include 
assessment of painful and temperature stimuli, as well as light touch, vibration, and 
proprioception to distal extremities. An important finding on sensory examination is a 
stocking pattern of sensory loss, which suggests concurrent somatic neuropathy. 
Coordination and gait are important to assess for an ataxic component to any suspected 
peripheral neuropathy. Specific abnormalities in autonomic functioning can be detected 
by using physical examination techniques, including the following: Measurement of  
lying, sitting, and orthostatic blood pressures to detect a postural especially if more than 
20 mm Hg of systolic pressure, or drop of 10 mm Hg in the presence of presyncopal 
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symptoms. Pulse should be measured concurrently to examine for loss of compensatory 
tachycardia and the presence of excessive tachycardia response in the case of POTS.25  
• Measurement of  blood pressure during isometric exercise (sustained hand grip). 
The patient squeezes a handgrip dynamometer with one hand to maximum 
capability. Following this, grip is then reduced to 25-30% of maximum pressure 
for approximately 5 minutes. The normal response for diastolic blood pressure is 
an increase of >16 mm Hg in the opposite arm.. Measurement of  postprandial 
blood pressures. An abnormal result would be to measure a drop in systolic blood 
pressure of >20 mm Hg approximately 15-20 minutes after a meal. Measurement 
of  multiple daily blood pressures to examine for diurnal fluctuation. A difference 
of <15 mm Hg with either systolic or diastolic blood pressure between daytime 
(awake) values and nighttime (sleeping) values could indicate presence of 
autonomic dysfunction26.  
• Measurement of  heart rate and blood pressure during a cold pressor test with 
hand immersed in ice cold water for at least 1 minute. The contralateral arm blood 
pressure is measured, with a drop of >10 mm Hg in diastolic blood pressure 
considered to be normal.  
 
• Measurement of  blood pressure and heart rate beat by beat during monitored 
respiratory activity as well as with Valsalva maneuver. 
 40
• Examination  for skin shriveling in response to holding the hand in water for a 
prolonged time.   
• Examination of  the palms, soles, and axillae for sweat.  
• Examination of pupillary responses to light and accommodation.  
• Examination  for presence of Horner syndrome with light palpation of both sides 
of the face to determine unilateral anhydrosis, assessment of pupillary size to 
determine miosis, and assessment for ptosis. .  
 
• Of note, ptosis in Horner syndrome is due to a sympathetic defect to Mueller   
muscle, which is found in both superior and inferior eyelids; therefore, Horner 
syndrome can produce a ptosis of both upper and lower eyelids.  
• Examination of the oral cavity for excessive dental caries in xerostomia. 
Examination of the conjunctiva and cornea for excessive scratches or signs of 
trauma due to xerophthalmia. Palpation of  the lower abdomen for detection of a 
distended bladder. 
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3. Aim  of  the Study 
     
                 The study was conducted with following specific objectives in mind.  
 
1. To investigate autonomic Dysfunctions in patients with cirrhosis of  varied etiology (in 
both alcoholics and non-alcoholics) 
 
2. To analyze characteristics of patients who develop autonomic dysfunction 
 
3. To determine the relationship between severity of liver damage and extent of 
autonomic function impairment. 
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4. Materials and Methods: 
Study Design : Case control study 
                    The study was conducted in Government General Hospital, Chennai, during 
the period   of   April 2006  to March 2007.and protocol of the study was submitted to the 
ethical committee  of the hospital and the approval was obtained . 
                     
                    The study was carried out on 40 patients with Cirrhosis (20 alcoholics - 80g 
of alcohol per day for 10 year and 20 non-alcoholics) and 40 age and sex matched 
controls in the Department of Medical Gastroenterology, Madras Medical College, 
Chennai.  
 
                  The diagnosis of Cirrhosis was made, on history, clinical examination, 
laboratory parameters, ultrasonographic findings, and the presence of oesophageal 
varices. The controls were healthy volunteers with no history of alcohol consumption and 
normal   clinical and biochemical parameters. A detailed clinical history with special 
reference to symptoms of autonomic disturbance was taken from each subject and a 
thorough physical examination including neurological assessment was carried out. 
                         
                A careful and complete history, as well as clinical examination as per proforma 
was performed. Following investigations were done for all patients. Complete blood 
counts, Bleeding time, Clotting time, Prothrombin time, Urinalysis, Stool examination for 
parasite and occult blood, Blood Sugar, Urea, Electrolytes, Creatinine, Serum Bilirubin 
SGOT, SGPT, Alkaline Phosphatase, Total protein, Albumin, Globulin, Ascitic fluid 
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protein, albumin, SAAG, amylase, cell count and cytology, viral markers like HBsAg, 
AntiHCV Ab, serum Cerulopalsmin in selected cases,   Chest X ray, USG abdomen, 
Doppler study of portal venous system  (in selected cases), and UGI endoscopy. 
                   
                Amount of ethanol intake, frequency and type were noted and so also about 
other drug usage. All the patients and the controls were subjected to a battery of five 
standard autonomic function tests as detailed below. 
Statistical analysis  was carried out  using SPSS windows 11.5 version. 
 
 
INCLUSION CRITERIA 
1. Symptoms and signs of parenchymal liver disease  in the form of  jaundice,  
swelling of legs and abdomen, unexplained asthenia, fever, anorexia, altered sleep 
pattern, bleeding tendency, spider nevi , palmar erythema, dupytren’s contracture, 
gynacomastia and astrexis. 
2. High SAAG ascites and or evidence of portal hypertension by clinical, 
endoscopic, Doppler ultra sound examination, and liver biopsies were performed 
whenever feasible. 
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EXCLUSION CRITERIA 
1. Patients diagnosed as acute viral hepatitis 
2. Liver secondaries with known or unknown primaries. 
3. Obstructive jaundice as evidenced by ultrasound, or ERCP 
4. Cases diagnosed to have Budd-Chiari syndrome, VOD, EHPVO or non cirrhotic 
portal hypertension. 
5. Cases where EHPVO or NCPF could not ruled out with certain after exhaustive 
testing 
6. Subjects who were known diabetes mellitus, ischemic heart disease and other 
medical conditions, and drugs that causes autonomic disturbance were excluded 
from the study. 
        
Tests reflecting sympathetic damage 
Blood pressure response to standing                                               
          This test measured the subject’s blood pressure with a sphygmomanometer while 
he was lying quietly and one minute after he was made to  stand up. The postural fall in 
blood pressure was taken as the difference between the systolic pressure lying and the 
systolic blood pressure standing. The test was repeated three times and the mean was 
calculated.27  
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Blood pressure response to sustained hand grip                            
                               The blood pressure of the patient was taken three times before the 
manoeuvre. A modified sphygmomanometer was used for sustained handgrip manoeuvre. 
The patient was asked to grip the inflatable rubber bag and apply maximum voluntary 
pressure possible. A reading from the attached mercury manometer was taken during 
maximum voluntary contraction.  
 
                            Thereafter, the patient was asked to maintain 30% of maximum 
voluntary contraction for as long as possible up to five minutes. Blood pressure was 
measured at one minute intervals during the handgrip. The result was expressed as the 
difference between the highest diastolic blood pressure during the handgrip exercise and 
the mean of the three diastolic blood pressure readings before the handgrip began.  
 
Tests reflecting cardiac parasympathetic damage 
Heart rate response to Valsalva manoeuvre. The subject was seated quietly and then 
asked to blow into a mouthpiece attached to a manometer, holding it at a pressure of 40 
mm Hg for 15 seconds while a continuous electrocardiogram (ECG) was recorded. The 
manoeuvre was repeated three times with one minute interval in between and results were 
expressed as:  
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Valsalva ratio = longest R-R interval after the manoeuvre ÷ shortest R-R interval during 
the manoeuvre. The mean of the three Valsalva ratios was taken as the final value.  
 
Heart rate (R-R interval) variation during deep breathing 
                      The subject was asked to breathe deeply at six breaths/min (five seconds 
"in" and five seconds "out") for one minute. An ECG was recorded throughout the period 
of deep breathing and onset of each inspiration and expiration was marked on ECG paper. 
The maximum and minimum R-R intervals during each breathing cycle were measured 
with a ruler and converted to beats/min. The results of the test were expressed as the 
mean of the difference between maximum and minimum heart rates for the six measured 
cycles in beats/min.  
 
Immediate heart rate response to standing 
                        The test was performed with the subject lying quietly on a couch while the 
heart rate was recorded continuously on an electrocardiograph. The patient was then 
asked to stand unaided and the point at starting to stand was marked on ECG paper. The 
shortest R-R interval at or around the 15th beat and the longest R-R interval at around the 
30th beat after starting to stand were measured with a ruler. The characteristic heart rate 
response was expressed by 30:15 ratios. Interpretation of tests was based on the works of 
Ewing and Clarke .The patients were categorised as normal, if none of the tests was 
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abnormal; with early parasympathetic damage, if results of one of the three tests of 
parasympathetic was abnormal; with definite parasympathetic damage, if two or more of 
the three tests of parasympathetic function were abnormal; and with combined damage, if 
one or both the tests of the sympathetic function were abnormal in addition to 
parasympathetic damage. For the purpose of the above mentioned classification the 
borderline tests were interpreted as normal. 
  
                             A scoring system like the one suggested by Bellavere et al was also 
utilized to assess the extent of autonomic nervous damage28 For each test "0" score was 
given for normal, "1" for borderline, and "2" for an abnormal value. By adding the score 
of each of the five standard tests of autonomic function, total autonomic function score 
was determined for every subject. 
 
                           A comparison of frequency of symptoms of autonomic dysfunction was 
made between cirrhotics and controls, and between alcoholic and non-alcoholic groups. A 
simple set of clinical and laboratory features as devised by Child and Turcotte (later 
modified by Pugh and named Child-Pugh criteria) were used in the study to quantify the 
severity of liver damage in patients. Scoring is done on the basis of degree of ascites, 
encephalopathy, hypoalbuminaemia, hyperbilirubinaemia, and hypoprothrombinaemia.  
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The score of each of the parameters in an individual is added to classify a patient as 
belonging to Child class A, B, or C . This grading of cirrhosis was originally devised to 
help select patients with cirrhosis for portal systemic shunt surgery and it has been shown 
to have prognostic value in several studies.  
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Picture :1 . Instrument  to assess  heart rate and  blood pressure response 
 
 
Picture 2: Heart  rate  response to Deep breathing 
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Picture 3: Blood pressure response to sustained Hand Grip 
 
 
                      Picture 4: Resting Heart rate variability. 
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5. Observations:  
 
                         The study group includes 40 patients with Cirrhosis (20 alcoholics and 20 
non-alcoholics) and 40 age and sex matched controls. Male:female ratio was 3:1. Twenty 
three (57.5%) were below 40 years of age. Common autonomic symptoms observed were 
dizziness while standing( 75%), pain in extremities(7.5%), palpitation(12.5%), and 
constipation (5%). Nine (22.5%) had family history of jaundice. Of which 3 had HBsAg 
positive, 2 were diagnosed to have Wilson disease and remaining 4 did not have any 
identifiable etiologies.   
 
                       Eleven (27%) patients had recent UGI bleed.Upper GI endoscopy showed 
Grade I (17), Grade II (15), Grade III (5) and 3 had no esophageal varices.  
Eighty percent (32) of patients with Cirrhosis were found to have evidence of autonomic 
Dysfunction. Of these, six (15%) patients had early parasympathetic damage, ten (25%) 
had definite parasympathetic damage, and sixteen (40%) had combined (that is, both 
parasympathetic and sympathetic) damage.  
                      Eighteen (90%) of the alcoholics and fourteen (70%) of the non-alcoholics 
had autonomic dysfunction.. Moreover, there was no significant association between 
subjective symptoms of autonomic dysfunction and objective evidence of autonomic 
damage as assessed by autonomic function tests. Autonomic dysfunction was 
significantly more frequent in advanced liver disease compared with early liver damage. 
One patient (50%)in Child A group , Eighteen (75%) out of 24 patients with  Chronic 
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liver disease belonging to Child class B and 13 (92.85%) of the 14 patients belonging to 
Child class C had autonomic dysfunction..  
 
                 The mean total autonomic function score were 0.45 for controls , 3.95 in Child 
class B and 6.53 in class C.(p value = 0.03) by (Mann-Whitney U test). The mean  
autonomic function scores for  alcoholics and  and non-alcoholics were 5.70 and 3.65 
respectively.( p value = 0.72 by Mann-Whitney U test). In  this study, heart rate response 
to standing was the most frequently (22 out of 40 patients) abnormal test in test group.   
In the present study, seven  patients had abnormal heart rate response to deep breathing, 
twelve had abnormal blood pressure response to sustained handgrip, and eleven  patients 
had an abnormal Valsalva ratio.  
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Table.1 : Child Turcotte Pugh  score 
Parameters Child A Child B Child C 
Ascites none slight Moderate/severe 
Encephalopathy none slight /moderate Moderate/severe 
Bilirubin mg/dl <2.0 2-3 >3.0 
Albumin g/dl >3.5 2.8-3.5 <2.8 
Prothrombin time 1-3 4-6 >6.0 
 
 
Table.2: Interpretation of autonomic function tests as normal, borderline, or abnormal 
depending on the value of the parameter measured 
 
Test Predominant  
Autonomicfunction 
tested 
Normal  Border line  Abnormal 
Valsalva ratio parasympathatic >1.21 1.11-1.20 <1.10 
Deep breathing  
(Max-Min heart beat /min) 
parasympathetic >15 11-14 <10 
Heart response to 
standing(30:15 ratio) 
parasympathetic >1.04 1.01-1.03 <1.00 
BP response to standing 
(fall in  blood pressure  in 
mm Hg) 
Sympathetic <10 11-29 >30 
BP response to sustained 
hand Grip 
(increasein diastolic 
pressure in mm of Hg) 
Sympathetic >16 11-15 <10 
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Table.3  Distribution of autonomic dysfunction  according to  Child class 
 
Group Child class A 
(n=2) 
Child class B 
(n=24) 
Child class C 
(n=14) 
Early parasympathetic damage 1 4 1 
Definite parasympathetic damage 0 6 4 
Combined damage 0 8 8 
Total 1 18 13 
 
 
Table.4  Distribution of autonomic dysfunction in alcoholics and non alcoholics 
 
     Parasympathetic damage   
Group early definite sympathetic combined 
Total (n=40) 6 10 16 16 
Alcoholics (n=20) 2 6 10 10 
Non Alcoholics(n=20) 4 4 6 6 
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Graph:1 Distribution of Child Class in the study population 
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Graph:2 Distribution of autonomic dysfunction according to  Child class 
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Graph:3 Distribution of autonomic dysfunction in alcoholics and non alcoholics 
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Graph:4.  Distribution of autonomic score in  patients according to their Child class  
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Graph:5.  Distribution of autonomic score in alcoholics and non alcoholics  
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Graph 6. Comparison of  Valsalva ratio and Heart rate response to Standing in 
alcoholic and non alcoholic Groups 
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Graph 7: Comparison of Heart rate response to deep breathing ,BP response to 
standing  and BP response to sustained hand grip in alcoholic and non alcoholic 
Groups 
 
 
Graph 8: Comparison of Valsalva ratio ,Heart rate response to deep breathing, 
Heart rate response  to standing  in  Child A, B. and C groups 
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6. Discussion: 
                         Autonomic nervous dysfunction is a known complication of diabetes28 
and alcohol abuse. Autonomic damage is expected in some patients with alcohol related 
cirrhosis since autonomic dysfunction, especially of vagal origin, is seen in chronic 
alcoholics29. Evidence for vagal neuropathy in alcoholic cirrhosis is well established by 
various studies30 However, in non-alcoholic cirrhosis there are conflicting reports.31 
                   Patients with cirrhosis and ascites have an activation of the sympathetic 
nervous system, as suggested by a higher than normal level of plasma norepinephrine, an 
augmented total body and individual organ norepinephrine spill-over rates, and an 
increased sympathetic nerve activity directly assessed by microneurographic techniques. 
The activation of the sympathetic nervous system is believed to playa major role in the 
pathogenesis of sodium retention and ascites has suggested by the inverse relationship 
between plasma norepinephrine and the urinary sodium excretion that is often observed 
in these patients.The possible role of the autonomic nervous system in the regulation of 
systemic hemodynamics  in cirrhosis has been evaluated using cardiovascular tests such 
as the deep breathing, the 30:15 ratio, and the Valsalva ratio tests, which are considered 
to estimate parasympathetic activity. The results of these tests were frequently abnormal 
in patients with both alcoholic and nonalcoholic liver diseases. Indeed, 43% of patients 
with nonalcoholic liver diseases had an abnormal Valsalva ratio, RR variations in deep 
breathing, and  response to intravenous atropine, suggesting a dysfunction of the 
parasympathetic nervous system.  
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\                                   In our study, 32 of the 40 chronic liver disease patients (80%) were found 
to have an abnormal result in one or more autonomic function tests. However, Barter and 
Tanner in their study of 30 subjects reported evidence of parasympathetic damage in 16% 
and of combined parasympathetic and sympathetic neuropathy in an additional 20%..The 
lower frequency of autonomic dysfunction in their study could be due to the fact that they 
included only 14 subjects with alcoholic liver disease while the rest had an alcohol 
dependence problem only.  
 
                      Szalay et al in their evaluation of 121 patients with chronic alcoholism—33 
without liver disease, 33 with fatty liver, 33 with cirrhosis, 10 with biliary cirrhosis, and 
12 with cirrhosis of another origin—found autonomic reflex damage in all.They observed 
significantly more damage in those with liver disease. Hendrickse and Triger reported 
cardiovascular autonomic dysfunction with predominantly parasympathetic abnormality 
in 35% of the patients with chronic liver disease.33  
 
                          Hendrickse et al in another study reported vagal neuropathy in 45% of 
the 60 patients of chronic liver disease studied.. The lower frequency of neuropathy is 
probably due to inclusion of mostly Child class A patients in the study (57 of the 60 
patients)34. Moreover, the study included a heterogeneous group of chronic liver disease 
patients with varying degrees of liver damage. In the present study, only one patient 
belonged to Child class A and the rest were class B or C.  
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                        Gentile et al found autonomic dysfunction in 60% (71% in the alcoholic 
group and 57% in the non-alcoholic group) of the 113 cirrhotics studied.35Like in the 
present study, alteration of parasympathetic function was significantly more frequent than 
that of sympathetic function. Dillon et al also detected abnormal cardiovascular reflexes 
in 60% of 70 cirrhotics.36 Their study group included as many as 42 patients belonging to 
Child class A and only 15 patients in class C.  
 
                       Gonzalez-Reimers et al have remarked in a study that in alcoholics, 
autonomic and peripheral neuropathy are dependent on each other and there is only weak 
correlation between liver function and both autonomic and peripheral neuropathy. In the 
present study no apparent relationship was noticed between autonomic and peripheral 
neuropathy, and autonomic damage was observed to be more common than peripheral 
neuropathy. The main object of the present study was to examine autonomic dysfunction 
and so, while careful systematic clinical examination was done in all the subjects, it is 
probable that more sensitive electrophysiological measurement would have yielded a 
much higher proportion of peripheral nerve abnormalities.  
                   Maheshwari -Thuluvath et al  in  their study remarked that Autonomic 
dysfunction is common in patients with chronic liver disease. For hitherto unknown 
reasons, in longitudinal studies, the presence of Autonomic dysfunction has been found to 
be an independent predictor of mortality in patients with cirrhosis.  They hypothesized 
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that patients with Autonomic dysfunction are more likely to develop hepatic 
encephalopathy (HE) due to prolonged intestinal transit time. In their  study, they  
examined the incidence of new-onset HE in patients with and without AN. Seventy-two 
patients (Child A/B/C = 35/31/6) without evidence of HE at the time of autonomic 
function testing (AFT) were followed for 39.5 +/- 27.3 months. The end point of the 
study was the development of new onset HE.  
                  Patients were followed until death or liver transplantation. Of the 72 patients, 
42 (58%) patients did not develop HE (group A) while 30 (42%) developed HE (group B) 
during the follow-up. Both groups had similar baseline demographics. AN was more 
common in group B (27/30; 90%) compared to group A (28/42; 67%) (P = 0.02). Kaplan-
Meier analysis showed a trend toward a higher incidence of HE in patients with 
Autonomic dysfunction . Mortality was higher in group B (12/30; 40%) compared to 
group A (8/42; 19%)  (P = 0.04). Patients with Autonomic dysfunction were more likely 
to develop new onset HE. Although an independent effect of Autonomic dysfunction  on 
HE was not established in that study, they speculated that delayed intestinal transit 
secondary to Autonomic dysfunction  may explain the higher incidence of HE in patients 
with AN. 
           In the present study, eighteen (75%) out of 24 patients belonging to Child 
class B had autonomic dysfunction while 13 (92.85%)  of the 14 patients in class C had 
impaired autonomic function. One patient (50%) in Child class A had autonomic damage. 
The mean total autonomic function score were 0.45 for controls were 0.45 for controls , 
3.95 in Child class B and 6.53 in class C. .(p value = 0.03)  The mean  autonomic function 
 63
scores for  alcoholics and  and non-alcoholics were 5.70 and 3.65 respectively  . These 
findings are similar to the observations of most other studies,37,38 which reported 
increasing frequency of autonomic dysfunction with increasing severity of liver damage. 
 
           Hendrickse and Triger reported a strong correlation between the abnormal 
tests and Child-Pugh score (p<0.0001). . In their study, they found autonomic dysfunction 
in 69% of Child class B and C patients and 23% in class A patients (p<0.0001). On the 
contrary, Gonzalez-Reimer et al in their study of 33 alcoholics, 20 of them cirrhotics, 
found a weak correlation between liver function and both autonomic and peripheral 
neuropathy.  
 
          Statistical comparison of cirrhotics and controls and alcoholics and non-
alcoholics revealed that light headedness on standing was significantly more frequent in 
cirrhotics compared with controls (p=0.001). However, no statistically significant 
association was noted between other symptoms or signs of autonomic dysfunction. This is 
similar to the findings of most of the studies available which found poor correlation 
between symptoms of autonomic dysfunction and objective evidence of autonomic 
dysfunction as assessed by the autonomic function tests39,40. In our study, no statistically 
significant difference was observed for various clinical features and laboratory 
parameters of liver failure between those with and without autonomic dysfunction. This is 
in contrast to the findings of Hendrickse et al who observed that patients with vagal 
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neuropathy were significantly older and tended to have lower serum albumin than those 
with normal cardiovascular test.41,42 
 
In our study, heart rate response to standing was the most frequently (22 out of 40 
patients) abnormal test in test group. Barter and Tanner in their study noted the heart rate 
response to standing as the most sensitive test with high specificity. Thuluvath and Triger 
in their study reported the heart rate response to deep breathing as the most sensitive test.  
However, it is noteworthy that this test depends on the cooperation of the subject and is, 
thus not as reproducible as the heart rate response to standing..  
 
                       Gentile et al remarked that deep breathing test and handgrip tests are the 
most influenced by the compliance of the patient..  In the study, they found the deep 
breathing test and lying to standing (heart rate response) tests to be most altered and the 
most sensitive and specific tests respectively. . In the present study, seven  patients had 
abnormal heart rate response to deep breathing, twelve had abnormal blood pressure 
response to sustained handgrip, and eleven  patients had an abnormal Valsalva ratio.  
             Finally, considering the adverse prognostic implications of autonomic 
dysfunction reported in cirrhotics, further prospective studies involving a larger number 
of patients are warranted to delineate the factors responsible for the derangement and find 
remedial measures if possible.  
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7. Conclusion:  
This study shows that autonomic dysfunction is common in patients with cirrhosis and it 
was comparable frequency both in alcoholics and non-alcoholics. It increases in severity 
with increase in extent of liver damage, suggesting that liver damage contributes to the 
neurological dysfunction 
 
8. Summary:  
It has been reported that the severity of autonomic dysfunction is proportional to the 
severity of cirrhosis, and its presence is an indicator of poor prognosis.  
This study was conducted   to investigate autonomic Dysfunctions in patients with 
cirrhosis of varied etiology, and to determine the relationship between severity of liver 
damage and extent of autonomic function impairment.  
• The present study included 40 patients with Cirrhosis   and 40 age and sex 
matched controls.  
• All the patients and the controls were subjected to a battery of five standard 
autonomic function tests. (Valsalva ratio, HR response to deep breathing, Heart 
rate response to standing, BP response to standing & BP response to sustained 
hand Grip) 
 
• Eighty percent (32) of patients with Cirrhosis were found to have evidence of 
autonomic Dysfunction. Of these, six (15%) patients had early parasympathetic 
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damage, ten (25%) had definite parasympathetic damage, and sixteen (40%) had 
combined (both parasympathetic and sympathetic) damage.  
• Eighteen (90%) of the alcoholics and fourteen (70%) of the non-alcoholics had 
autonomic dysfunction.  
• Autonomic dysfunction was significantly abnormal in advanced liver disease 
compared with early liver damage.  
• Light headedness on standing was the most common symptom of autonomic 
dysfunction which was more frequently observed in cirrhotics compared with 
controls (p=0.001). 
• One patient (50%) in Child class A group, eighteen (75%) in Child class B and 13 
(92.85%) in Child class C had autonomic dysfunction. 
• There was no significant association between symptoms of autonomic dysfunction 
and objective evidence of autonomic damage 
• None of our patients was found to have sympathetic dysfunction alone.  
• Parasympathetic damage was always found in association with an evidence of 
sympathetic damage. 
• The mean (SD) total autonomic function scores in patients with cirrhosis and 
controls were 4.57(1.84) and 0.45 (0.57) respectively and it was statistically 
significant (p<0.01).  
• Total autonomic function scores in alcoholics (5.70), and non-alcoholics (3.65) 
were not found to be statistically significant (p>0.05). 
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• Autonomic dysfunction was found to be proportional to the severity of cirrhosis. 
The mean total autonomic function score in Child class B and in class C were 
3.95 & 6.53 respectively. 
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                                                             9. Annexure –I 
 
Proforma 
 
                                               Date: 
                                                                                                                         GE no: 
1. Name       : 
2. Age/sex    : 
3. Address   :                                                                        
4. History 
 
Abdominal distension 
 
Abdominal pain 
 
UGI bleeding 
 
Jaundice 
 
Altered sensorium 
 
Fever 
 
Pedal edema 
 
Symptoms of autonomic dysfunction   :                          
1. Dizziness while Standing 
2. Altered sweating 
3. Pain in extremities - exposure to cold Reynaud’s phenomenon 
4. Palpitation 
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5. Constipation 
6. Nausea, vomiting 
7. Difficulty in swallowing 
8. Feeling full after eating little 
9. Eye irritation/decreased lacrimation 
10. Urinary frequency/ hesitancy 
5. Drug history                 : 
 
6. Family History             : 
 
7. Habits                            :  
    
    Alcohol abuse                        
 
 
8. BMI                               : 
 
9. General examination    :   
 
10. Abdominal examination: 
 
11. Investigations: 
 
   Liver function test      : 
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   CTP score                   : 
 
   USG abdomen             : 
 
   UGI Endoscopy           : 
 
Autonomic function tests 
  
12.Basal Recordings 
 Heart Rate   
 Blood Pressure               
13.Orthostatic standing Test 
 HR (30/15) 
 B.P.  (supine)   
 B.P.  Standing  
14.Deep Breathing   
 HR 
15.Valsalva Maneuver  
 HR 
16.Isometric Hand Grip  
 B.P         
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Master Chart  Control Group
S.No Age sex    AN symptoms Drug history Family History Total Valsalva ratio Score Deep breath score HR Score BP 1 score BP 2 score
1 40 2 0 2 0 1 1.22 0 16 0 1.05 0 16 1 16 0
2 30 1 0 2 0 1 1.24 0 16 0 1.06 0 12 0 18 0
3 35 1 0 2 0 1 1.24 0 18 0 1.08 0 14 1 20 0
4 46 2 4 2 0 1 1.22 0 18 0 1.06 0 14 1 20 0
5 32 1 0 2 1 1 1.28 0 16 0 1.07 0 12 0 18 0
6 55 1 4 2 0 1 1.26 0 17 0 1.06 0 14 1 18 0
7 46 1 1 2 0 0 1.23 0 17 0 1.06 0 6 0 20 0
8 15 1 1 2 1 0 1.24 0 16 0 1.06 0 6 0 18 0
9 27 2 4 2 0 0 1.22 0 18 0 1.08 0 8 0 18 1
10 42 2 4 2 0 0 1.23 0 16 0 1.07 0 6 0 18 1
11 37 1 1 2 1 0 1.24 0 17 0 1.09 0 6 0 16 0
12 30 1 1 2 1 0 1.26 0 16 0 1.08 0 8 0 16 1
13 40 1 1 2 1 0 1 22 0 18 0 1 06 0 6 0 16 0. .
14 25 2 1 2 0 0 1.25 0 18 0 1.06 0 8 0 18 1
15 37 1 0 2 1 0 1.22 0 18 0 1.08 0 6 1 18 0
16 40 1 5 2 1 0 1.26 0 16 0 1.08 0 6 0 16 0
17 36 1 0 2 1 0 1.26 0 16 0 1.06 0 4 0 20 1
18 45 2 0 2 1 0 1.26 0 18 0 1.08 0 8 0 20 0
19 34 1 0 2 1 0 1.22 0 16 0 1.06 0 6 0 18 0
20 45 2 0 2 1 1 1.28 0 12 1 1.06 0 4 0 14 0
21 40 1 1 2 0 1 1.26 0 14 1 1.06 0 6 0 12 1
22 47 1 1 2 1 1 1.12 1 12 1 1.08 0 6 0 12 0
23 34 1 1 2 1 1 1.18 1 12 1 1.08 0 6 0 16 1
24 45 1 1 2 0 1 1.24 0 14 1 1.06 0 8 0 12 1
25 41 1 1 2 1 0 1.22 0 16 0 1.06 0 8 1 12 0
26 26 1 1 2 1 0 1.26 0 16 0 1.07 0 6 0 12 1
27 35 2 3 2 0 1 1.24 0 14 1 1.08 0 8 0 12 0
28 22 2 6 2 0 1 1.22 0 16 0 1.06 0 12 1 12 1
29 33 1 0 2 0 1 1.24 0 18 0 1.06 0 14 1 14 0
S.No Age sex    AN symptoms Drug history Family History Total Valsalva ratio Score Deep breath score HR Score BP 1 score BP 2 score
30 35 1 0 2 0 1 1.24 0 18 0 1.06 0 12 1 12 1
31 42 1 0 2 0 0 1.26 0 16 0 1.06 0 8 0 18 0
32 41 2 0 2 1 0 1.24 0 16 0 1.07 0 6 0 18 0
33 18 1 0 2 1 0 1.22 0 16 0 1.09 0 6 0 20 0
34 24 2 0 2 0 0 1.22 0 18 0 1.06 0 6 0 20 0
35 34 1 5 2 0 1 1.24 0 16 0 1.04 1 8 0 18 0
36 46 1 6 2 1 1 1.14 1 16 0 1.06 0 6 0 20 0
37 40 2 0 2 1 0 1.22 0 18 0 1.08 0 8 0 18 0
38 38 1 0 2 1 0 1.23 0 16 0 1.02 1 6 0 20 0
39 20 2 0 2 1 0 1.22 0 16 0 1.06 0 8 0 18 0
40 27 2 0 2 0 0 1.24 0 18 0 1.06 0 6 0 16 0
Male -1 1 Dizziness while Stand1 yes 1 jaundice >1 21= 0 >15 = 0 >1 04 = 0 <10 = 0 >16 = 0  .   . . .    .       
Female -2 2. Altered sweating 2.no 2.diabetes 1.11–1.20 = 1  11–14 = 1 1.01–1.03 = 1  11–29 = 1 11–15 = 1
3. Pain in extremities 3.HT <1.10 = 2  <10 = 2  <1.00 = 2 >30 = 2  <10 = 2
4. Palpitation
5. Constipation Valsalva ratio Deep breathing Heart rate BP 1 BP 2
6. Nausea, vomiting  test (max-min heart response to response response to 
7. Difficulty in swallowing  rate beats/min) standing  (30:15 ratio) to standing sustained hand grip
8. Feeling full after eating little
9. Eye irritation/decreased lacrimation
10. Urinary frequency/ hesitancy
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